Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide

In this large real-world cohort, PSA response at 6 months was a strong predictor of disease progression, supporting its use as a dynamic prognostic biomarker.

Authors

Institutions

Publication Details

Journal
The Prostate
Published
2025-09-04
DOI
https://doi.org/10.1002/pros.70040
Citations
1
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide

Raquel Sopeña Sutil, Almudena Cascales, Jesús Muñoz Rodríguez, José Alemán et al.
1 citations
The Prostate
Prostate Cancer Treatment and Research
1.52
article

Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide

Raquel Sopeña Sutil, Almudena Cascales, Jesús Muñoz Rodríguez, José Alemán, C. Osorio, Juan Gómez Rivas, Antoni Vilaseca, Marta Román, Christopher Concha, A. Bonet, M. Backhaus, Estefanía Linares, Manel Beamud Cortés, Sara Martínez Breijo, Miguel García Sanz, Pedro de Pablos‐Rodríguez, Natalia Picola Brau, Meritxell Pérez Márquez, Á. Zamora Horcajada, Marc Costa Planells, J.M. De La Morena Gallego, E. Ríos González, Pol Servián Vives, Victor Rodríguez Part, Natalia Domínguez Esteban
article en
1 citations

Abstract

In this large real-world cohort, PSA response at 6 months was a strong predictor of disease progression, supporting its use as a dynamic prognostic biomarker.

The ProstateVol. 85(16)
Andalusian Health Service (ES), Hospital Universitario La Paz (ES), Bellvitge University Hospital (ES), Hospital Clínico San Carlos (ES), Consorci Sanitari de Terrassa (ES), Marqués de Valdecilla University Hospital (ES), Hospital Universitario Fundación Alcorcón (ES), Hospital Universitario 12 De Octubre (ES), Fundación Instituto Valenciano de Oncología (ES), Hospital Universitario Príncipe de Asturias (ES), Hospital Clínic de Barcelona (ES), Vall d'Hebron Hospital Universitari (ES), Complexo Hospitalario Universitario A Coruña (ES), Hospital Universitari de Tortosa Verge de la Cinta (ES), Hospital Universitari Germans Trias i Pujol (ES), Instituto de Investigación Biomédica de A Coruña (ES), Hospital Universitario de León (ES), Hospital Universitario Infanta Sofía (ES), Instituto Nacional de la Salud (ES), Complejo Asistencial Universitario de Palencia (ES), Deleted Institution, University of Chile (CL)
Openalex Percentile: Top 15%
Prostate Cancer Treatment and Research
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.